The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial of BMS-986205 and nivolumab as first-line therapy in hepatocellular carcinoma.
 
Justin Chen
No Relationships to Disclose
 
Jingran Ji
No Relationships to Disclose
 
May Thet Cho
No Relationships to Disclose
 
Arta Monjazeb
No Relationships to Disclose
 
Sepideh Gholami
No Relationships to Disclose
 
Edward Jae-Hoon Kim
Honoraria - ARMO BioSciences; Vicus Therapeutics
Consulting or Advisory Role - ARMO BioSciences; Vicus Therapeutics
Research Funding - Boston Biomedical (Inst); Celgene (Inst); EpicentRx (Inst); Halozyme (Inst); Merck (Inst); OncoMed (Inst)